DATOPOTAMAB
UNII BA3HQU7PO9

Substance Identification & Data

This profile provides standardized clinical and technical data for Datopotamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BA3HQU7PO9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2267989-53-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

BA3HQU7PO9

CAS Registry Number

2267989-53-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DATOPOTAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C174638

National Cancer Institute reference terminology for clinical and research data.

INN ID

11347

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-51

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Datopotamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DATOPOTAMAB

Common Names & Synonyms

DATOPOTAMAB [INN]

DATOPOTAMAB [USAN]

IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR-ASSOCIATED CALCIUM SIGNAL TRANSDUCER 2) (HUMAN-MUS MUSCULUS MONOCLONAL MAAP-9001A .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MAAP-9001A .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TACSTD2 (TUMOR-ASSOCIATED CALCIUM SIGNAL TRANSDUCER 2, MEMBRANE COMPONENT CHROMOSOME 1 SURFACE MARKER 1, M1S1, GASTROINTESTINAL TUMOR-ASSOCIATED ANTIGEN GA7331, PANCREATIC CARCINOMA MARKER PROTEIN GA733-1, EPITHELIAL GLYCOPROTEIN-1, EGP-1, TROPHOBLAST ANTIGEN-2, CELL SURFACE GLYCOPROTEIN TROP-2, TROP2)), HUMANIZED MONOCLONAL ANTIBODYGAMMA1 HEAVY CHAIN HUMANIZED (1-451) (VH (HOMO SAPIENS IGHV1-3*01 (79.6%)-(IGHD)-IGHJ4*01 (93.3%)) (8.8.14) (1-121)-HOMO SAPIENS IGHG1*03 (100%) G1M3, NG1M1 (CH1 R120 (218) (122-219), HINGE 1-15 (220-234), CH2 (235-344), CH3 E12 (360), M14 (362) (345-449), CHS (450-451)) (118-451)), (224-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-39*01 (84.2%)-IGKJ2*01 (100%)) (6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214'))DIMER (230-230'':233-233'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA

External Clinical & Regulatory Resources

Previous UNIIBA3CCX3UY4

Next UNIIBA3SM6E7RK